{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:41:21Z","timestamp":1794336081977,"version":"4.9.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ijcard.2025.133182","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T01:01:57Z","timestamp":1742518917000},"page":"133182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Pathophysiology of heart failure with preserved ejection fraction in overweight and obesity - Clinical and treatment implications"],"prefix":"10.1016","volume":"430","author":[{"given":"Mariana M.","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Menezes","family":"Falc\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ijcard.2025.133182_bb0005","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2025.133182_bb0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.metabol.2018.11.001","article-title":"Obesity and cancer risk: emerging biological mechanisms and perspectives","volume":"92","author":"Avgerinos","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.ijcard.2025.133182_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.583175","article-title":"Emerging role of adipocyte dysfunction in inducing heart failure among obese patients with prediabetes and known diabetes mellitus","volume":"7","author":"Berezin","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"issue":"18","key":"10.1016\/j.ijcard.2025.133182_bb0020","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/cvr\/cvac120","article-title":"Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets","volume":"118","author":"Borlaug","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"43","key":"10.1016\/j.ijcard.2025.133182_bb0025","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1093\/eurheartj\/ehw241","article-title":"Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction","volume":"37","author":"Borlaug","year":"2016","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.ijcard.2025.133182_bb0030","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/s41591-023-02526-x","article-title":"Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial","volume":"29","author":"Borlaug","year":"2023","journal-title":"Nat. Med."},{"issue":"18","key":"10.1016\/j.ijcard.2025.133182_bb0035","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","article-title":"Heart failure with preserved ejection fraction: JACC scientific statement","volume":"81","author":"Borlaug","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2025.133182_bb0040","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur. J. Heart Fail."},{"issue":"10","key":"10.1016\/j.ijcard.2025.133182_bb0045","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/ejhf.2947","article-title":"Global longitudinal strain predicts clinical outcomes in patients with heart failure with preserved ejection fraction","volume":"25","author":"Brann","year":"2023","journal-title":"Eur. J. Heart Fail."},{"issue":"40","key":"10.1016\/j.ijcard.2025.133182_bb0050","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1093\/eurheartj\/ehad541","article-title":"Diabetocardiology: a new subspecialty?","volume":"44","author":"Braunwald","year":"2023","journal-title":"Eur. Heart J."},{"issue":"22","key":"10.1016\/j.ijcard.2025.133182_bb0055","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.jacc.2023.09.811","article-title":"Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction","volume":"82","author":"Butler","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10437","key":"10.1016\/j.ijcard.2025.133182_bb0060","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0140-6736(24)00469-0","article-title":"Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials","volume":"403","author":"Butler","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2025.133182_bb0065","article-title":"Finerenone, obesity, and heart failure with mildly reduced\/preserved ejection fraction: Prespecified analysis of FINEARTS-HF","author":"Butt","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2025.133182_bb0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/VHRM.S168946","article-title":"Obesity paradox in cardiovascular disease: where do we stand?","volume":"15","author":"Carbone","year":"2019","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.ijcard.2025.133182_bb0075","doi-asserted-by":"crossref","DOI":"10.15420\/cfr.2022.23","article-title":"Pathophysiological rationale and clinical evidence for Neurohormonal modulation in heart failure with preserved ejection fraction","volume":"9","author":"Castiglione","year":"2023","journal-title":"Card. Fail. Rev."},{"key":"10.1016\/j.ijcard.2025.133182_bb0080","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fcvm.2020.00022","article-title":"Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease","volume":"7","author":"Chait","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ijcard.2025.133182_bb0085","article-title":"Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonists","author":"Cimino","year":"2023","journal-title":"ESC Heart Fail."},{"issue":"2","key":"10.1016\/j.ijcard.2025.133182_bb0090","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ehf2.14560","article-title":"Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonists","volume":"11","author":"Cimino","year":"2024","journal-title":"ESC Heart Fail"},{"issue":"19","key":"10.1016\/j.ijcard.2025.133182_bb0095","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.ijcard.2025.133182_bb0100","first-page":"Cd003641","article-title":"Surgery for weight loss in adults","volume":"2014","author":"Colquitt","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.ijcard.2025.133182_bb0105","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00592-014-0644-5","article-title":"Clinical efficacy of bariatric surgery versus liraglutide in patients with type 2 diabetes and severe obesity: a 12-month retrospective evaluation","volume":"52","author":"Cotugno","year":"2015","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.ijcard.2025.133182_bb0110","article-title":"Diabetes mellitus and heart failure with preserved ejection fraction: role of obesity","volume":"12","author":"Dhore-Patil","year":"2021","journal-title":"Front. Physiol."},{"issue":"10","key":"10.1016\/j.ijcard.2025.133182_bb0115","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"14","author":"Dunlay","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcard.2025.133182_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.674254","article-title":"Natriuretic peptide clearance receptor (NPR-C) pathway as a novel therapeutic target in obesity-related heart failure with preserved ejection fraction (HFpEF)","volume":"12","author":"Egom","year":"2021","journal-title":"Front. Physiol."},{"issue":"21","key":"10.1016\/j.ijcard.2025.133182_bb0125","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022930","article-title":"Pragmatic weight management program for patients with obesity and heart failure with preserved ejection fraction","volume":"10","author":"El Hajj","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"9","key":"10.1016\/j.ijcard.2025.133182_bb0130","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/ejhf.1909","article-title":"Spironolactone dose in heart failure with preserved ejection fraction: findings from TOPCAT","volume":"22","author":"Ferreira","year":"2020","journal-title":"Eur. J. Heart Fail."},{"issue":"8","key":"10.1016\/j.ijcard.2025.133182_bb0135","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jchf.2020.06.003","article-title":"Epicardial adipose tissue and invasive hemodynamics in heart failure with preserved ejection fraction","volume":"8","author":"Gorter","year":"2020","journal-title":"JACC Heart Fail"},{"issue":"5","key":"10.1016\/j.ijcard.2025.133182_bb0140","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamacardio.2021.0372","article-title":"Comparison of New York heart association class and patient-reported outcomes for heart failure with reduced ejection fraction","volume":"6","author":"Greene","year":"2021","journal-title":"JAMA Cardiol."},{"issue":"18","key":"10.1016\/j.ijcard.2025.133182_bb0145","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2025.133182_bb0150","article-title":"Weight change and mortality risk in heart failure with preserved ejection fraction","volume":"8","author":"Huang","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"22","key":"10.1016\/j.ijcard.2025.133182_bb0155","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1161\/CIRCULATIONAHA.115.018226","article-title":"Adipocyte-derived hormone leptin is a direct regulator of aldosterone secretion, which promotes endothelial dysfunction and cardiac fibrosis","volume":"132","author":"Huby","year":"2015","journal-title":"Circulation"},{"issue":"26","key":"10.1016\/j.ijcard.2025.133182_bb0160","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/eurheartj\/ehz295","article-title":"Surgical obesity treatment and the risk of heart failure","volume":"40","author":"Jamaly","year":"2019","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcard.2025.133182_bb0165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ijcard.2025.133182_bb0170","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4330\/wjc.v14.i9.473","article-title":"Thirty-day readmission in patients with heart failure with preserved ejection fraction: insights from the nationwide readmission database","volume":"14","author":"Jha","year":"2022","journal-title":"World J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2025.133182_bb0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3904\/kjim.2022.271","article-title":"Obesity-related heart failure with preserved ejection fraction: diagnostic and therapeutic challenges","volume":"38","author":"Jung","year":"2023","journal-title":"Korean J. Intern. Med."},{"issue":"6","key":"10.1016\/j.ijcard.2025.133182_bb0180","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1002\/ehf2.13619","article-title":"Impact of weight loss in patients with heart failure with preserved ejection fraction: results from the FLAGSHIP study","volume":"8","author":"Kamisaka","year":"2021","journal-title":"ESC Heart Failure"},{"key":"10.1016\/j.ijcard.2025.133182_bb0185","doi-asserted-by":"crossref","DOI":"10.15420\/cfr.2023.03","article-title":"Epidemiology, clinical characteristics and cause-specific outcomes in heart failure with preserved ejection fraction","volume":"9","author":"Kapelios","year":"2023","journal-title":"Card. Fail. Rev."},{"issue":"9","key":"10.1016\/j.ijcard.2025.133182_bb0190","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41591-019-0563-7","article-title":"Contribution of genetics to visceral adiposity and its relation to cardiovascular and metabolic disease","volume":"25","author":"Karlsson","year":"2019","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.ijcard.2025.133182_bb0195","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2025.133182_bb0200","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jama.2015.17346","article-title":"Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial","volume":"315","author":"Kitzman","year":"2016","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.ijcard.2025.133182_bb0205","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2016.05.019","article-title":"The HFpEF obesity phenotype: the elephant in the room","volume":"68","author":"Kitzman","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2025.133182_bb0210","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae508","article-title":"Obesity and cardiovascular disease: an ESC clinical consensus statement","author":"Koskinas","year":"2024","journal-title":"Eur. Heart J."},{"issue":"24","key":"10.1016\/j.ijcard.2025.133182_bb0215","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1001\/jama.2020.23138","article-title":"Effect of digoxin vs Bisoprolol for heart rate control in atrial fibrillation on patient-reported quality of life: the RATE-AF randomized clinical trial","volume":"324","author":"Kotecha","year":"2020","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.ijcard.2025.133182_bb0220","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jcjd.2016.12.003","article-title":"Impact of bariatric surgery on white adipose tissue inflammation","volume":"41","author":"Labrecque","year":"2017","journal-title":"Can. J. Diabetes"},{"issue":"2","key":"10.1016\/j.ijcard.2025.133182_bb0225","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.atherosclerosis.2010.09.012","article-title":"Visceral adiposity and the severity of coronary artery disease in middle-aged subjects with normal waist circumference and its relation with lipocalin-2 and MCP-1","volume":"213","author":"Lee","year":"2010","journal-title":"Atherosclerosis"},{"issue":"14","key":"10.1016\/j.ijcard.2025.133182_bb0230","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ehj.2004.06.006","article-title":"Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart failure survey","volume":"25","author":"Lenzen","year":"2004","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.ijcard.2025.133182_bb0235","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/ejhf.1149","article-title":"Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum","volume":"20","author":"Lund","year":"2018","journal-title":"Eur. J. Heart Fail."},{"issue":"16","key":"10.1016\/j.ijcard.2025.133182_bb0240","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJMe2411214","article-title":"FINEARTS-HF \u2014 the latest masterpiece for MRAs in heart failure","volume":"391","author":"McDonagh","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"37","key":"10.1016\/j.ijcard.2025.133182_bb0245","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.ijcard.2025.133182_bb0250","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/obr.12707","article-title":"Effects of intentional weight loss in patients with obesity and heart failure: a systematic review","volume":"19","author":"McDowell","year":"2018","journal-title":"Obes. Rev."},{"issue":"5","key":"10.1016\/j.ijcard.2025.133182_bb0255","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.119.044491","article-title":"Effects of Sacubitril-valsartan versus valsartan in women compared with men with heart failure and preserved ejection fraction: insights from PARAGON-HF","volume":"141","author":"McMurray","year":"2020","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcard.2025.133182_bb0260","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/oby.22038","article-title":"Bariatric surgery-induced cardiac and Lipidomic changes in obesity-related heart failure with preserved ejection fraction","volume":"26","author":"Mikhalkova","year":"2018","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"10.1016\/j.ijcard.2025.133182_bb0265","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41569-020-00480-6","article-title":"Cellular and molecular pathobiology of heart failure with preserved ejection fraction","volume":"18","author":"Mishra","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"Supplement_1","key":"10.1016\/j.ijcard.2025.133182_bb0270","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab724.0729","article-title":"Hospitalization and mortality in heart failure with preserved ejection fraction: real-world data from a US integrated healthcare delivery system","volume":"42","author":"Nichols","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2025.133182_bb0275","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.metabol.2018.12.006","article-title":"Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine","volume":"92","author":"Nimptsch","year":"2019","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.ijcard.2025.133182_bb0280","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcard.2025.133182_bb0285","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cardfail.2022.09.018","article-title":"Epidemiology, pathophysiology, diagnosis, and therapy of heart failure with preserved ejection fraction in Japan","volume":"29","author":"Obokata","year":"2023","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2025.133182_bb0290","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-med-042220-022745","article-title":"Heart failure with preserved ejection fraction: mechanisms and treatment strategies","volume":"73","author":"Omote","year":"2022","journal-title":"Annu. Rev. Med."},{"issue":"3","key":"10.1016\/j.ijcard.2025.133182_bb0295","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.ijcard.2025.133182_bb0300","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","article-title":"Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium","volume":"71","author":"Packer","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcard.2025.133182_bb0305","first-page":"633","article-title":"Obesity-related heart failure with a preserved ejection fraction: the mechanistic rationale for combining inhibitors of aldosterone, Neprilysin, and sodium-glucose Cotransporter-2","volume":"6","author":"Packer","year":"2018","journal-title":"JACC: Heart Failure"},{"issue":"9","key":"10.1016\/j.ijcard.2025.133182_bb0310","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/ejhf.1902","article-title":"Characterization of the inflammatory-metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease","volume":"22","author":"Packer","year":"2020","journal-title":"Eur. J. Heart Fail."},{"issue":"0","key":"10.1016\/j.ijcard.2025.133182_bb0315","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"0","author":"Packer","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2025.133182_bb0320","series-title":"GLP-1 Receptor Agonists among Patients with Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors","author":"Patel","year":"2024"},{"issue":"12","key":"10.1016\/j.ijcard.2025.133182_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2023.100705","article-title":"Heart failure with preserved ejection fraction with CKD: a narrative review of a multispecialty disorder","volume":"5","author":"Patel","year":"2023","journal-title":"Kidney Med."},{"issue":"9","key":"10.1016\/j.ijcard.2025.133182_bb0330","first-page":"1907","article-title":"Intentional weight loss in overweight and obese patients with heart failure: a systematic review","volume":"26","author":"Peck","year":"2024","journal-title":"Eur. J. Heart Fail."},{"issue":"15","key":"10.1016\/j.ijcard.2025.133182_bb0335","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.ijcard.2025.133182_bb0340","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1093\/eurheartj\/ehn420","article-title":"Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme","volume":"29","author":"Pocock","year":"2008","journal-title":"Eur. Heart J."},{"issue":"27","key":"10.1016\/j.ijcard.2025.133182_bb0345","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/eurheartj\/eht085","article-title":"Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines","volume":"34","author":"Quercioli","year":"2013","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.ijcard.2025.133182_bb0350","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/eurheartj\/ehr029","article-title":"Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity","volume":"32","author":"Quercioli","year":"2011","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.ijcard.2025.133182_bb0355","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jacc.2020.07.009","article-title":"Atrial dysfunction in patients with heart failure with preserved ejection fraction and atrial fibrillation","volume":"76","author":"Reddy","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.ijcard.2025.133182_bb0360","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.2023.2020","article-title":"Heart failure with preserved ejection fraction: a review","volume":"329","author":"Redfield","year":"2023","journal-title":"Jama"},{"issue":"11","key":"10.1016\/j.ijcard.2025.133182_bb0365","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrendo.2017.90","article-title":"Adapting to obesity with adipose tissue inflammation","volume":"13","author":"Reilly","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.ijcard.2025.133182_bb0370","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ejhf.521","article-title":"Abdominal adiposity, general obesity, and subclinical systolic dysfunction in the elderly: a population-based cohort study","volume":"18","author":"Russo","year":"2016","journal-title":"Eur. J. Heart Fail."},{"issue":"2","key":"10.1016\/j.ijcard.2025.133182_bb0375","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/cvr\/cvaa217","article-title":"Metabolic inflammation in heart failure with preserved ejection fraction","volume":"117","author":"Schiattarella","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.ijcard.2025.133182_bb0380","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11897-013-0166-4","article-title":"Ventricular remodeling in heart failure with preserved ejection fraction","volume":"10","author":"Shah","year":"2013","journal-title":"Curr. Heart Fail. Rep."},{"issue":"12","key":"10.1016\/j.ijcard.2025.133182_bb0385","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.ijcard.2025.133182_bb0390","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ijcard.2025.133182_bb0395","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.3390\/jcm12093341","article-title":"Obesity, preserved ejection fraction heart failure, and left ventricular remodeling","volume":"12","author":"Stencel","year":"2023","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2025.133182_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25020794","article-title":"Heart failure with preserved ejection fraction: the pathophysiological mechanisms behind the clinical phenotypes and the therapeutic approach","volume":"25","author":"Stoicescu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ijcard.2025.133182_bb0405","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1097\/HJH.0000000000000614","article-title":"Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs - overview and meta-analyses","volume":"33","author":"Thomopoulos","year":"2015","journal-title":"J. Hypertens."},{"issue":"11","key":"10.1016\/j.ijcard.2025.133182_bb0410","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/ejhf.2363","article-title":"The diverging role of epicardial adipose tissue in heart failure with reduced and preserved ejection fraction: not all fat is created equal","volume":"23","author":"Tromp","year":"2021","journal-title":"Eur. J. Heart Fail."},{"issue":"8","key":"10.1016\/j.ijcard.2025.133182_bb0415","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jchf.2018.03.006","article-title":"Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction","volume":"6","author":"Tsao","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"6","key":"10.1016\/j.ijcard.2025.133182_bb0420","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13755","article-title":"Coronary circulatory function with increasing obesity: a complex U-turn","volume":"52","author":"Upadhyaya","year":"2022","journal-title":"Eur. J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.ijcard.2025.133182_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.100936","article-title":"PET\/CT assessment of flow-mediated Epicardial vasodilation in obesity and severe obesity","volume":"3","author":"Valenta","year":"2024","journal-title":"JACC Adv."},{"issue":"36","key":"10.1016\/j.ijcard.2025.133182_bb0430","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur. Heart J."},{"issue":"20","key":"10.1016\/j.ijcard.2025.133182_bb0435","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013441","article-title":"Noncardiac versus cardiac mortality in heart failure with preserved, midrange, and reduced ejection fraction","volume":"8","author":"Vergaro","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.ijcard.2025.133182_bb0440","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/HCO.0000000000001113","article-title":"Obesity\/cardiometabolic phenotype of heart failure with preserved ejection fraction: mechanisms to recent trials","volume":"39","author":"Verma","year":"2024","journal-title":"Curr. Opin. Cardiol."},{"issue":"24","key":"10.1016\/j.ijcard.2025.133182_bb0445","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.2016.7050","article-title":"Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged \u226575 years: a randomized clinical trial","volume":"315","author":"Williamson","year":"2016","journal-title":"Jama"},{"issue":"22","key":"10.1016\/j.ijcard.2025.133182_bb0450","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2025.133182_bb0455","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/CIRCRESAHA.120.318805","article-title":"Immunometabolic endothelial phenotypes: integrating inflammation and glucose metabolism","volume":"129","author":"Xiao","year":"2021","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.ijcard.2025.133182_bb0460","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.apsb.2023.01.012","article-title":"Pathophysiology of obesity and its associated diseases","volume":"13","author":"Xin Jin","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"6","key":"10.1016\/j.ijcard.2025.133182_bb0465","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/jcsm.12803","article-title":"Prognostic score based on physical frailty in patients with heart failure: a multicenter prospective cohort study (FLAGSHIP)","volume":"12","author":"Yamada","year":"2021","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"9386","key":"10.1016\/j.ijcard.2025.133182_bb0470","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ijcard.2025.133182_bb0475","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00392-018-1302-7","article-title":"Body mass index and all-cause mortality in heart failure patients with normal and reduced ventricular ejection fraction: a dose\u2013response meta-analysis","volume":"108","author":"Zhang","year":"2019","journal-title":"Clin. Res. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2025.133182_bib476","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005126","article-title":"Gastric Bypass Surgery Produces a Durable Reduction in Cardiovascular Disease Risk Factors and Reduces the Long-Term Risks of Congestive Heart Failure","volume":"6","author":"Benotti","year":"2017","journal-title":"J. Am Heart Assoc."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527325002256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527325002256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T13:43:49Z","timestamp":1744897429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527325002256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":96,"alternative-id":["S0167527325002256"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.133182","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiology of heart failure with preserved ejection fraction in overweight and obesity - Clinical and treatment implications","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.133182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"133182"}}